Snyder, Gretchen L. http://orcid.org/0000-0003-4749-686X
Li, Peng
Martin, Terry
Zhang, Lei
Yao, Wei
Zheng, Hailin
Maguire, David R.
Gerak, Lisa R.
Vanover, Kimberly E.
France, Charles P.
Davis, Robert
Article History
Received: 9 November 2023
Accepted: 15 March 2024
First Online: 6 May 2024
Declarations
:
: This work was supported in part by Intra-Cellular Therapies, Inc. (ITCI). ITI-333 is an investigational new drug under development by ITCI. GLS, PL, TM, WY, LZ, HZ, KEV, and RED are current or former employees of ITCI and may hold ITCI stock or stock options.